Senti Biosciences Holdings, Inc. (SNTI) Net Income by Year
Senti Biosciences Holdings, Inc. reported a net loss of $61.4M in fiscal year 2025. This represents a decrease of 16.4% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Senti Biosciences Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SNTI Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SNTI Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Senti Biosciences Holdings, Inc. financials
Frequently Asked Questions
What was Senti Biosciences Holdings, Inc.'s net income in fiscal year 2025?
Senti Biosciences Holdings, Inc. reported a net loss of $61.4M in fiscal year 2025.
How fast is Senti Biosciences Holdings, Inc.'s net income growing?
Senti Biosciences Holdings, Inc. (SNTI) net income fell by 16.4% year over year, from -$52.8M to -$61.4M in fiscal year 2025.
How has Senti Biosciences Holdings, Inc.'s net income changed over the years?
Across the 5 fiscal years this page covers, Senti Biosciences Holdings, Inc. (SNTI) net income went from -$55.3M in fiscal year 2021 to -$61.4M in fiscal year 2025.
What was Senti Biosciences Holdings, Inc.'s net income in the most recent quarter?
Senti Biosciences Holdings, Inc. (SNTI) reported -$12.8M in net income in Q2 2026. This represents an increase of 13.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Senti Biosciences Holdings, Inc. (SNTI) reported on that line in every period on record.